SurModics Newsroom

SurModics | 10-K: FY2024 Annual Report

SECNov 20 21:52 · Announcements

CORRECTION: Surmodics Reported Q4 Financial Results on Nov. 6

BenzingaNov 13 21:03

Surmodics Shares Are Trading Lower. The Company Reported Q4 Financial Results.

BenzingaNov 13 21:02

SurModics (SRDX) Is an Incredible Growth Stock: 3 Reasons Why

Yahoo FinanceNov 13 01:45

Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down

Zacks Nov 7 22:35

Barrington Maintains SurModics(SRDX.US) With Hold Rating

Futu NewsNov 7 22:35 · Ratings

Hold Rating Maintained for SurModics Amid Acquisition Uncertainty

TipRanksNov 7 22:25

Surmodics Analyst Ratings

BenzingaNov 7 17:42 · Ratings

Needham Maintains SurModics(SRDX.US) With Hold Rating

Futu NewsNov 7 00:32 · Ratings

Needham Sticks to Their Hold Rating for SurModics (SRDX)

TipRanksNov 6 23:55

Surmodics Non-GAAP EPS of -$0.13 Beats by $0.16, Revenue of $33.2M Beats by $2.8M

Seeking AlphaNov 6 23:09

Express News | Surmodics Inc: Co Is Not Introducing Financial Guidance for Fiscal 2025 in Light of Pending Acquisition by Gtcr

BreakingsNov 6 20:07

Express News | Surmodics Inc: Qtrly Total Rev $33.2 Mln

BreakingsNov 6 20:06

Earnings Flash (SRDX) SURMODICS Posts Q4 Revenue $33.2M

MT NewswiresNov 6 20:04

SurModics | 8-K: Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

SECNov 6 20:02

Express News | Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

BreakingsNov 6 20:00

Express News | Surmodics Q4 Net Income USD -3.449 Million

BreakingsNov 6 20:00

Press Release: Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Dow JonesNov 6 20:00

Surmodics 4Q Loss $3.45M >SRDX

Dow JonesNov 6 20:00

Surmodics Announces Early Subset Analysis Of 60 Patients With Acute, Subacute, Or Chronic Symptoms Of Limb Ischemia Demonstrated 96.8% Procedural Flow Restoration, With 81.7% Of Subjects Not Receiving Additional Thromboemboli Removal Treatment Post...

BenzingaOct 31 02:31